You have 9 free searches left this month | for more free features.

adenoid cystic carcinoma

Showing 1 - 25 of 9,430

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in United States

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • San Francisco, California
  • +5 more
Nov 1, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Adenoid Cystic Carcinoma of the Head and Neck Trial (OBT076, Balstilimab)

Not yet recruiting
  • Adenoid Cystic Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Adenoid Cystic Carcinoma Trial in Heidelberg (Carbon ion irradiation, Bimodal irradiation)

Recruiting
  • Adenoid Cystic Carcinoma
  • Carbon ion irradiation
  • Bimodal irradiation
  • Heidelberg, Germany
    University of Heidelberg, Radiooncology, HIT
Oct 31, 2022

Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • Adenoid Cystic Carcinoma of the Salivary Gland
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
  • +1 more
Sep 22, 2022

Carcinoma, Adenoid Cystic, Head Neck Cancer Trial in Pavia (simultaneous integrated boost of carbon ions radiation therapy)

Not yet recruiting
  • Carcinoma, Adenoid Cystic
  • Head and Neck Cancer
  • simultaneous integrated boost of carbon ions radiation therapy
  • Pavia, Italy
    CNAO
Feb 8, 2023

Adenoid Cystic Carcinoma Trial in Boston (Radiation, Pembrolizumab)

Completed
  • Adenoid Cystic Carcinoma
  • Boston, Massachusetts
  • +1 more
Oct 8, 2022

Salivary Gland Cancer Trial in Cincinnati (Amivantamab)

Recruiting
  • Salivary Gland Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Aug 5, 2022

68Ga-FAPI PET/CT, Metastatic Adenoid Cystic Carcinoma Trial in Beijing (68Ga-FAPI)

Recruiting
  • 68Ga-FAPI PET/CT
  • Metastatic Adenoid Cystic Carcinoma
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Aug 10, 2022

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Houston (AL101, Therapeutic Conventional Surgery)

Recruiting
  • Adenoid Cystic Carcinoma
  • Metastatic Adenoid Cystic Carcinoma
  • AL101
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)

Recruiting
  • Adenoid Cystic Carcinoma
  • Salivary Gland Cancer
  • Miami, Florida
  • +7 more
Oct 26, 2022

Adenoid Cystic Carcinoma Trial in United States (Lenvatinib)

Active, not recruiting
  • Adenoid Cystic Carcinoma
  • Basking Ridge, New Jersey
  • +5 more
Jun 1, 2022

Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)

Completed
  • Recurrent ACC, metastaticACC, Unreaectable ACC
  • Seoul, Korea, Republic of
    Department of Internal Medicine, Seoul National University Hospi
Mar 26, 2022

Adenoid Cystic Carcinoma Trial in United States (Regorafenib)

Active, not recruiting
  • Adenoid Cystic Carcinoma
  • Basking Ridge, New Jersey
  • +4 more
Apr 26, 2022

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Boston (Standard of Care, SBRT)

Recruiting
  • Adenoid Cystic Carcinoma
  • Metastatic Adenoid Cystic Carcinoma
  • Standard of Care
  • SBRT
  • Boston, Massachusetts
  • +1 more
Dec 29, 2021

Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)

Recruiting
  • Carcinoma, Adenoid Cystic
  • EGFR-TK Inhibitor
  • Qingdao, Shandong, China
    Qingdao central Hospital
Nov 1, 2021

Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Melbourne (TetMYB Vaccine, BGB-A317)

Active, not recruiting
  • Colorectal Cancer
  • Adenoid Cystic Carcinoma
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
May 16, 2022

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022

Adenoid Cystic Carcinoma Trial in Boston (Tretinoin)

Completed
  • Adenoid Cystic Carcinoma
  • Boston, Massachusetts
  • +1 more
Jul 15, 2021

Adenoid Cystic Carcinomas, Cisplatin Trial in Shanghai (Chidamide combined with cisplatin)

Completed
  • Adenoid Cystic Carcinomas
  • Cisplatin
  • Chidamide combined with cisplatin
  • Shanghai, Shanghai, China
    Kai Xue
Aug 18, 2021

Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 5, 2022

Adenoid Cystic Carcinoma Trial in Worldwide (AL101)

Active, not recruiting
  • Adenoid Cystic Carcinoma
  • Los Angeles, California
  • +16 more
Dec 10, 2021

Adenoid Cystic Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)

Recruiting
  • Adenoid Cystic Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 18, 2021